Most cited papers from Central Dermatology

Central Dermatology

What are the most cited papers from Central Dermatology?

The most cited paper from Central Dermatology is "Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics" (Alan Menter et al., 2019), with 970 citations. Next come "European S3‐Guidelines on the systemic treatment of psoriasis vulgaris" (705) and "Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study" (510).

Published TypeFieldAccessCitations

Showing 50 of 59 papers. Every paper with more than 67 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics Alan Menter et al. · Journal of the American Academy of Dermatology	13 Feb 2019	970
2	European S3‐Guidelines on the systemic treatment of psoriasis vulgaris Delano Pathirana et al. · Journal of the European Academy of Dermatology and Venereology Open access	26 Aug 2009	705
3	Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study Kenneth B. Gordon, Richard G B Langley, Craig L. Leonardi et al. · Journal of the American Academy of Dermatology	11 Aug 2006	510
4	Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities Craig A. Elmets et al. · Journal of the American Academy of Dermatology	13 Feb 2019	503
5	Hidradenitis suppurativa Samantha R. Goldburg, Bruce E Strober, Michael J. Payette · Journal of the American Academy of Dermatology	9 Oct 2019	488
6	Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study Joann G. Elmore, Raymond L. Barnhill, David E. Elder et al. · BMJ Open access	28 Jun 2017	436
7	Bimekizumab versus Secukinumab in Plaque Psoriasis Kristian Reich, Richard Bruce Warren, Mark Lebwohl et al. · New England Journal of Medicine	23 Apr 2021	427
8	Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial April Wang Armstrong, Melinda Gooderham, Richard Bruce Warren et al. · Journal of the American Academy of Dermatology Open access	9 Jul 2022	371
9	Border detection in dermoscopy images using statistical region merging M. Emre Celebi, Hassan A. Kingravi, Hitoshi Iyatomi et al. · Skin Research and Technology Open access	19 Mar 2008	366
10	Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies Alan Menter et al. · Journal of the American Academy of Dermatology	28 Feb 2020	354
11	Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures Craig A. Elmets et al. · Journal of the American Academy of Dermatology	29 Jul 2020	349
12	IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development Courtney Smith, Mee Young Chang, Katherine H. Parker et al. · Cancer Discovery Open access	20 Jul 2012	327
13	Atypical lipoma, atypical intramuscular lipoma, and well differentiated retroperitoneal liposarcoma.A reappraisal of 30 cases formerly classified as well differentiated liposarcoma Harry L. Evans, Edward H. Soule, RICHARD K. WINKELMANN · Cancer	Feb 1979	308
14	Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial Bruce E Strober, Diamant Thaçi, Howard L. Sofen et al. · Journal of the American Academy of Dermatology Open access	14 Sep 2022	299
15	Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council Bruce E Strober et al. · Journal of the American Academy of Dermatology Open access	16 Aug 2019	258
16	Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients Alan Menter et al. · Journal of the American Academy of Dermatology	5 Nov 2019	224
17	Pilomatrix carcinoma or calcifying epitheliocarcinoma of malherbe. A case report and review of literature Sumala Lopansri, Martín C. Mihm · Cancer Open access	May 1980	205
18	Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy Craig A. Elmets et al. · Journal of the American Academy of Dermatology	25 Jul 2019	202
19	Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis Mark Lebwohl, Linda Stein Gold, Bruce E Strober et al. · New England Journal of Medicine	8 Dec 2021	194
20	Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis Alan Menter, Kenneth B. Gordon, Craig L. Leonardi et al. · Journal of the American Academy of Dermatology	4 Jun 2010	164
21	Diameter of Involved Nerves Predicts Outcomes in Cutaneous Squamous Cell Carcinoma with Perineural Invasion AMY SIMON ROSS, Faith Miller Whalen, Rosalie Elenitsas et al. · Dermatologic Surgery	3 Nov 2009	158
22	Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2) Alice Bendix Gottlieb, Andrew Blauvelt, Diamant Thaçi et al. · Journal of the American Academy of Dermatology Open access	13 Apr 2018	157
23	Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switches Andrew Blauvelt, J.‐P. Lacour, Joseph F. Fowler et al. · British Journal of Dermatology	19 Jun 2018	153
24	The MPATH-Dx reporting schema for melanocytic proliferations and melanoma Michael W. Piepkorn, Raymond L. Barnhill, David E. Elder et al. · Journal of the American Academy of Dermatology Open access	28 Oct 2013	135
25	Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data Bruce E Strober, Craig L. Leonardi, Kim Alexander Papp et al. · Journal of the American Academy of Dermatology Open access	23 Nov 2016	131
26	Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis Alice Bendix Gottlieb, C. Leonardi, Francisco A. Kerdel et al. · British Journal of Dermatology	17 May 2011	130
27	Diagnostic Performance of Deep Learning Algorithms Applied to Three Common Diagnoses in Dermatopathology Thomas George Olsen, B. Hunter Jackson, Theresa Ann Feeser et al. · Journal of Pathology Informatics Open access	2018	123
28	A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial* Andrew Blauvelt, C. Leonardi, Boni Elizabeth Elewski et al. · British Journal of Dermatology Open access	2 Sep 2020	122
29	Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis Mark Lebwohl et al. · JAMA Open access	20 Sep 2022	117
30	Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet Craig L. Leonardi, Richard G B Langley, Kim Alexander Papp et al. · Archives of Dermatology	21 Dec 2010	116
31	Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial Akimichi Morita, Bruce E Strober, A. David Burden et al. · The Lancet	19 Sep 2023	114
32	Tailored for Real-World: A Whole Slide Image Classification System Validated on Uncurated Multi-Site Data Emulating the Prospective Pathology Workload Julianna D. Ianni, Rajath Elias Soans, Sivaramakrishnan Sankarapandian et al. · Scientific Reports Open access	21 Feb 2020	114
33	A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis James G. Krueger, Mayte Suárez‐Fariñas, Inna Cueto et al. · PLoS ONE Open access	10 Nov 2015	104
34	Cutaneous involvement in Hodgkin's disease Robert M. White, James W. Patterson · Cancer	Mar 1985	104
35	Impact of adalimumab treatment on patient‐reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis Dennis A. Revicki, Mary Kaye Willian, Alan Menter et al. · Journal of Dermatological Treatment	2007	103
36	Extranodal Rosai‐Dorfman Disease of the Head and Neck James W. Goodnight, Marilene B. Wang, Joel A. Sercarz et al. · The Laryngoscope	Mar 1996	102
37	One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial Bruce E Strober, Linda Stein Gold, Robert Bissonnette et al. · Journal of the American Academy of Dermatology Open access	27 Jun 2022	96
38	Five‐year maintenance of clinical response and health‐related quality of life improvements in patients with moderate‐to‐severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2* Kristian Reich, Kenneth B. Gordon, Bruce E Strober et al. · British Journal of Dermatology Open access	9 Jun 2021	85
39	Safety and Efficacy of Erbium-Doped Yttrium Aluminum Garnet Fractionated Laser for Treatment of Acne Scars in Type IV to VI Skin Bassel H. Mahmoud, Divya Srivastava, Jennifer J. Janiga et al. · Dermatologic Surgery	2 Apr 2010	85
40	Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis C. Leonardi, Alan Menter, Tiffani K. Hamilton et al. · British Journal of Dermatology Open access	29 Mar 2008	84
41	Dermatologic Features of Classic Movie Villains Julie Amthor Croley, Vail Reese, Richard F. Wagner · JAMA Dermatology Open access	7 Apr 2017	83
42	A survey of skin disease and skin-related issues in Arab Americans Dina F. El‐Essawi, Joseph L. Musial, Adnan S Hammad et al. · Journal of the American Academy of Dermatology	23 Feb 2007	83
43	Extracellular Matrix Injury during Lung Inflammation Edward J. Campbell, Robert M. Senior, Howard G. Welgus · CHEST Journal	Jul 1987	83
44	Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease Alexandra Heurgué, Fabien Vitry, Marie-Danièle Diébold et al. · Gastroentérologie Clinique et Biologique	2007	81
45	Microbiology of Obstructive Tonsillar Hypertrophy and Recurrent Tonsillitis I. H. Kielmovitch, G Keleti, Charles D. Bluestone et al. · Archives of Otolaryngology - Head and Neck Surgery	Jun 1989	77
46	Subcutaneous efalizumab is not effective in the treatment of alopecia areata Vera H. Price, Maria Kramarczuk Hordinsky, Elise A. Olsen et al. · Journal of the American Academy of Dermatology	15 Feb 2008	75
47	The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis Craig L. Leonardi, Kim Alexander Papp, Bruce E Strober et al. · American Journal of Clinical Dermatology Open access	Oct 2011	74
48	A retrospective study of canine and feline cutaneous vasculitis Patrick R. Nichols, Daniel O. Morris, Karin Muth Beale · Veterinary Dermatology	Oct 2001	73
49	Discoid Lupus Erythematosus of the Eyelids Cheryl Huey, Frederick A. Jakobiec, Takeo Iwamoto et al. · Ophthalmology	Dec 1983	73
50	Computed tomography staging of the paranasal sinuses in chronic hyperplastic rhinosinusitis William H. Friedman, George P. Katsantonis, Michael C. Sivore et al. · The Laryngoscope	Nov 1990	73

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.